Quantcast
Channel: BioHealth Investor » AEZS
Browsing all 3 articles
Browse latest View live

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL,...

We have already seen a massive round of abstracts ahead of the huge American Society of Clinical Oncology, or ASCO meeting for 2009, which is scheduled to start this weekend.  ASCO is usually thought...

View Article



AEterna Zentaris Partner Keryx Reports Positive Phase 2 Data for Perifosine...

Keryx Biopharmaceuticals, Inc (Nasdaq: KERX) a partner of AEterna Zentaris (Nasdaq: AEZS) has announced positive results in its phase II trial of its advanced metastatic colon cancer drug, Perifosine....

View Article

AEterna Zentaris (AEZS) Stock Crushed On Research Results: Stock Off 65%

AEterna Zentaris (AEZS) reported Phase 3 results for its North American efficacy trial Z-033 and the safety trial Z-041 in benign prostatic hyperplasia (BPH), with its lead endocrinology compound for...

View Article
Browsing all 3 articles
Browse latest View live




Latest Images